Industry reacts to TGA down-scheduling decision with cautious optimism by Martin Lane December 17, 2020December 17, 2020 The industry has broadly welcomed the Therapeutic Goods Administration’s decision to down schedule low-dose CBD – […]
Analysis: The battle to restore value to the Australian cannabis sector by Steve Jones August 27, 2020September 1, 2020
Analysis: why government underfunding is putting Australian medical cannabis users at risk by Steve Jones August 12, 2020August 13, 2020
PODCAST: Cannabiz goes live; a new industry body launches; and the Senate inquiry into patient access by Josie Tutty July 30, 2020August 6, 2020
